Menu

AAAS Fellowship to Chemist Repealed

Technician’s death in Patrick Harran’s lab prompted the American Association for the Advancement of Science to yank Harran’s title as a fellow.

Dec 23, 2015
Kerry Grens

WIKIMEDIA, BRENT - UCLAThe American Association for the Advancement of Science (AAAS) had elected Patrick Harran, a biochemist at the University of California, Los Angeles (UCLA), to join its prestigious club of fellows in 2015. But upon further review—specifically, of the death of a technician in a 2008 fire in Harran’s lab—AAAS rescinded the nomination.

“On December 18, the AAAS Council approved the Chemistry Section steering group’s request to conduct a complete re-evaluation of Dr. Harran’s nomination after it became apparent that an initial review of nomination materials had not included all relevant information,” AAAS announced in a statement this week (December 22).

Harran’s selection to become a AAAS fellow was met with criticism. Family members of Sheharbano “Sheri” Sangji, who was killed in the lab fire, said in a letter to AAAS, “no principal investigator who runs their laboratory in a criminally negligent manner as Patrick Harran has should be bestowed with any awards. We respectfully request that you refuse to honor the unsafe science conducted by an unethical scientist.”

Harran paid a $10,000 fine and served 800 hours of community service after he was charged with health and safety code violations.

UCLA released a statement expressing disappointment in AAAS’s move. “Although all concerned lament the tragic laboratory accident that occurred in 2008, Professor Harran’s work has important implications for cancer research and deserves recognition.” 

Naveen Sangji, Sangji’s sibling, said in a statement to Chemistry World: “In rescinding UCLA professor Patrick Harran’s nomination, the AAAS leadership has taken a stance in support of laboratory safety.”

The AAAS fellows subcommittee said it is reconsidering its process for nominating fellows.

Update (December 24): Prompted by Harran's nomination, the American Chemical Society (ACS) was inspired to consider adding safety criteria to its rules for nominating society fellows, reported Chemical & Engineering News (C&EN, which is published by ACS). “At an ACS Board of Directors meeting on Dec. 14, current President Diane Grob Schmidt requested that the board review and reinforce its commitment to safety through its national awards and fellows program, as well as by adding safety to the society’s core values and strengthening references to safety in the Chemical Professional's Code of Conduct,”according to C&EN.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.